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Abstract
TNF is an important mediator of glomerulonephritis. The two TNF-receptors TNFR1 and TNFR2 contribute differently to
glomerular inflammation in vivo, but specific mechanisms of TNFR-mediated inflammatory responses in glomeruli are
unknown. We investigated their expression and function in murine kidneys, isolated glomeruli ex vivo, and glomerular cells
in vitro. In normal kidney TNFR1 and TNFR2 were preferentially expressed in glomeruli. Expression of both TNFRs and TNF-
induced upregulation of TNFR2 mRNA was confirmed in murine glomerular endothelial and mesangial cell lines. In vivo, TNF
exposure rapidly induced glomerular accumulation of leukocytes. To examine TNFR-specific inflammatory responses in
intrinsic glomerular cells but not infiltrating leukocytes we performed microarray gene expression profiling on intact
glomeruli isolated from wildtype and Tnfr-deficient mice following exposure to soluble TNF ex vivo. Most TNF-induced
effects were exclusively mediated by TNFR1, including induced glomerular expression of adhesion molecules, chemokines,
complement factors and pro-apoptotic molecules. However, TNFR2 contributed to TNFR1-dependent mRNA expression of
inflammatory mediators in glomeruli when exposed to low TNF concentrations. Chemokine secretion was absent in TNF-
stimulated Tnfr1-deficient glomeruli, but also significantly decreased in glomeruli lacking TNFR2. In vivo, TNF-induced
glomerular leukocyte infiltration was abrogated in Tnfr1-deficient mice, whereas Tnfr2-deficiency decreased mononuclear
phagocytes infiltrates, but not neutrophils. These data demonstrate that activation of intrinsic glomerular cells by soluble
TNF requires TNFR1, whereas TNFR2 is not essential, but augments TNFR1-dependent effects. Previously described TNFR2-
dependent glomerular inflammation may therefore require TNFR2 activation by membrane-bound, but not soluble TNF.
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Introduction
Cytokines produced by intrinsic renal cells and infiltrating
leukocytes are central mediators of inflammatory kidney diseases.
Tumor necrosis factor-a (TNF) is involved in glomerular
inflammation and scarring [1,2]. Renal expression of TNF is up-
regulated in experimental animals and patients with glomerulo-
nephritis (GN) [3,4,5,6]. TNF is produced by macrophages, T
cells, neutrophils and endothelium. Furthermore, intrinsic renal
cells, including mesangial cells, podocytes, and tubular epithelial
cells produce TNF upon stimulation [4,7,8,9,10,11].
The functional role of TNF in GN has been demonstrated in
animal models. Systemic administration of TNF induced glomer-
ular damage in rabbits [12] and exacerbated glomerular injury in
rats with nephrotoxic serum nephritis (NTN), a model of immune
complex-mediated GN [13]. TNF-deficient mice subjected to
NTN demonstrated reduced proteinuria, glomerular crescent
formation, infiltration of leukocytes, and expression of vascular
adhesion molecules [14]. In bone marrow chimeric mice it was
shown that intrinsic renal cells are the major source of TNF
contributing to renal injury in the NTN model [15,16]. TNF
blockade also attenuated glomerular lesions and crescent forma-
tion in rats developing anti-glomerular basement membrane
antibody-induced crescentic GN [17,18,19].
Biological activities of TNF are mediated through two
functionally distinct TNF receptors (TNFR), TNFR1 (CD120a)
and TNFR2 (CD120b). An increased glomerular expression of
TNFR1 and TNFR2 has been suggested by animal and human
biopsy studies of GN [6,20]. We have previously identified distinct
proinflammatory roles of the two TNFRs in the development of
glomerular injury in murine NTN. Tnfr1-deficiency delayed the
onset of GN, whereas deficiency of intrinsic renal cell-expressed
TNFR2 abrogated glomerular injury following immune complex
deposition [20]. Underlying mechanisms of these differential
TNFR-mediated inflammatory responses in the glomerulus are
not known.
With TNF receptor-targeted interventions becoming a potential
therapeutic strategy to reduce glomerular inflammation, mecha-
nisms of TNFR-specific inflammatory responses in glomeruli
remain to be elucidated. Here, we characterize TNFR1- and
TNFR2-dependent glomerular inflammatory pathways in murine
kidneys in vivo, in isolated glomeruli ex vivo, and in murine
mesangial cells in vitro. Microarray gene expression profiling on
intact glomeruli isolated from wildtype and Tnfr-deficient mice
demonstrated that soluble TNF mediates most inflammatory
effects in glomeruli via TNFR1-dependent mRNA induction of
proinflammatory mediators, including adhesion molecules and
chemokines. TNFR2 contributed to TNFR1-dependent effects
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after stimulation with low TNF concentrations. In addition, we
identified a posttranscriptional role of TNFR2 in enhancing
chemokine secretion. Consistent with these in vitro results, we
demonstrated a predominant role of TNFR1 in mediating soluble
TNF-induced glomerular leukocyte accumulation in vivo, with a
selective contribution of TNFR2 to the accumulation of glomer-
ular mononuclear phagocytes. Together, these data suggest that
activation of intrinsic glomerular cells by soluble TNF requires
TNFR1, whereas TNFR2 augments TNFR1-dependent effects. In
contrast, no exclusively TNFR2-dependent inflammatory path-
ways were identified in soluble TNF-stimulated glomeruli. These
data suggest that mice deficient for renal cell-expressed TNFR2
are protected from GN in vivo [20] as a result from blocked
TNFR2 activation by membrane-bound TNF, but not soluble
TNF in intrinsic glomerular cells.
Materials and Methods
Animals
Mouse strains with targeted deletion of TNFR1 (Tnfr12/2,
B6.129-Tnfrsf1atm1Mak) and 2 (Tnfr22/2, B6.129-Tnfrsf1btm1Mwm)
were originally purchased from the Jackson Laboratory (Bar
Harbor, ME, USA) and bred in our Central Animal Facility
(University Hospital Innenstadt, Ludwig-Maximilians-University
Munich) under specific pathogen-free conditions. Tnfr1 and 2
double-deficient mice (Tnfr1,22/2) and C57BL/6J wildtype
controls were generated by cross-breeding of single Tnfr-deficient
mice. Renal leukocyte infiltration was induced in 6 to 8 week old
male mice by intraperitoneal injection of 5 mg recombinant
murine TNF (Invitrogen, Karlsruhe, Germany). Perfused kidneys
were harvested eight hours after TNF injection. Untreated male
mice were used for paramagnetic isolation of glomeruli subse-
quently analyzed in ex vivo experiments. All experimental
procedures involving mice were approved by the Ethical
Committee of the Regierung von Oberbayern (AZ 55.2-1-54-
2532.3-8-12).
Paramagnetic Isolation of Glomeruli
Isolation of glomeruli from mouse kidneys was essentially
performed as described by Takemoto and coworkers [21].
Briefly, M-450 tosylactivated, 4.5 mm diameter Dynabeads
(Invitrogen, Karlsruhe, Germany) were inactivated according
to the manufacturer`s instructions. Mice were perfused with
86107 paramagnetic Dynabeads diluted in 40 ml of phosphate-
buffered saline (PBS; Pan Biotech, Aidenbach, Germany)
through the heart with a constant pressure of 40 mmHg using
a custom-made, pressure-controlled syringe. Kidneys were
digested with 1 mg/ml collagenase A (Roche Diagnostics,
Mannheim, Germany) in 1 ml Hanks` balanced salt solution
(HBSS; Pan Biotech) at 37uC for 30 minutes. The digested
Figure 1. Expression of TNFR1 and TNFR2 in mouse kidney. A: Compartment-specific expression of TNFR1 and TNFR2 mRNA in glomeruli and
tubulointerstitial tissue isolated from normal mouse kidney as analyzed by quantitative real-time PCR. Values were normalized to rRNA expression
used as reference gene. p,0.05. B: Immunohistochemistry on frozen sections for TNFR1 and TNFR2 protein demonstrates a prominent glomerular
expression of both receptors (black color product) in normal mouse kidney. Original magnification x200.
doi:10.1371/journal.pone.0068167.g001
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tissue was passed through a 100 mm cell strainer (BD
Biosciences, Heidelberg, Germany). The cell suspension con-
taining glomeruli with trapped paramagnetic Dynabeads was
placed into a magnetic particle concentrator (Invitrogen) for 7
minutes. The first supernatant was pipetted into a separate tube
and stored on ice. The remaining tissue was resuspended in
10 ml PBS, and placed again into the magnetic particle
concentrator for 5 minutes. The supernatant was removed
and remaining paramagnetically labelled glomeruli were resus-
pended in 4 ml PBS and passed through a 100 mm cell strainer.
This suspension was placed again in the magnetic particle
separator for 5 minutes, the supernatant discarded, and the
remaining tissue was washed three times with 10 ml PBS.
Finally, purified glomeruli were resuspended in 1.5 ml of PBS.
All procedures were performed on ice except the collagenase
digestion at 37uC. Samples of all obtained fractions were viewed
microscopically. The final paramagnetically labelled fraction
contained highly purified glomeruli with a yield of approxi-
mately 10,000 glomeruli per mouse kidney and a purity .97%
(intact glomeruli versus tubular fragments or single cells). As
previously described, isolated glomeruli were lacking the Bow-
man`s capsule [21]. The first supernatant was free of glomeruli,
but contained tubular fragments, single tubular cells and
polymorphic interstitial cells.
Cell Culture
A murine glomerular endothelial cell line was originally
derived from tsA58 immorto mice [22] and generously provided
by Dr. Nese Akis (Division of Microbiology, Uludag University,
Bursa, Turkey). Cells were grown in DMEM medium with
GlutaMax (Invitrogen) supplemented with 10% fetal calf serum
(FCS; Biochrom, Berlin, Germany), 100 U/ml penicillin and
100 mg/ml streptomycin (PAA Laboratories, Pasching, Austria).
The endothelial cells were characterized by positive immuno-
staining for CD31, von Willebrand factor, and cytokeratin 18. A
murine mesangial cell line was maintained in DMEM supple-
mented with 2.5% FCS and penicillin-streptomycin as described
[23]. Reaching 80% confluency cells were serum starved for 24
hours and subsequently stimulated with murine TNF (Invitro-
gen) or IFN-c (PeproTech, Rocky Hill, NJ, USA) in DMEM for
5 hours (endothelial cells) or 24 hours (mesangial cells).
Primary murine mesangial cells (pMC) were prepared from
C57BL/6J wildtype and Tnfr-deficient mice following paramag-
netic isolation of glomeruli as previously described [24]. After
five passages, pMC were characterized by positive immuno-
staining for a-smooth muscle actin and desmin, and by negative
staining for CD31, von Willebrand factor and cytokeratin 18.
Being 80% confluent pMC from passages 7–8 were serum
starved for 24 hours and subsequently stimulated with indicated
concentrations of murine TNF in RPMI 1640 for 12 hours.
Glomerular Culture and Stimulation
After isolation 5,000 intact glomeruli were resuspended in 3 ml
RPMI 1640 supplemented with 15% FCS, 15 mM HEPES buffer
(Invitrogen), 0.66 U/ml insulin and penicillin-streptomycin, and
Figure 2. Expression of TNFR1 and TNFR2 in glomerular endothelial and mesangial cells in vitro. A: Expression of TNFR1 mRNA in
unstimulated, TNF-stimulated and IFN-c-stimulated glomerular endothelial cells. Cells were stimulated with indicated concentrations of TNF and/or
IFN-c for 5 hours. B: Expression of TNFR2 mRNA in unstimulated, TNF-stimulated and IFN-c-stimulated glomerular endothelial cells. Cells were
stimulated as in A. C: Expression of TNFR1 mRNA in unstimulated, TNF-stimulated and IFN-c-stimulated mesangial cells. Cells were stimulated with
indicated concentrations of TNF and/or IFN-c for 24 hours. D: Expression of TNFR2 mRNA in unstimulated, TNF-stimulated and IFN-c-stimulated
glomerular endothelial cells. Cells were stimulated as in C. mRNA expression levels were analyzed by quantitative real-time PCR. Values were
normalized to GAPDH expression used as reference gene. p,0.05, ,0.01 (A-D). E: TNFR1 surface expression in unstimulated, TNF-stimulated and
IFN-c-stimulated glomerular endothelial cells in vitro analyzed by flow cytometry. Cells were stimulated with indicated concentrations of TNF and/or
IFN-c for 5 hours. F: TNFR2 surface expression in unstimulated, TNF-stimulated and IFN-c-stimulated glomerular endothelial cells. Cells were
stimulated as in E. G: Flow cytometric analysis of TNFR1 surface expression in unstimulated, TNF-stimulated and IFN-c-stimulated mesangial cells
in vitro. Cells were treated with indicated concentrations of TNF and IFN-c for 24 hours. H: TNFR2 surface expression in unstimulated, TNF-stimulated
and IFN-c-stimulated mesangial cells. Cells were stimulated as in G. The percentage of TNFR-positive cells was determined in comparison to the
respective isotype controls. p,0.05 versus medium control (E-H). Data are mean and SD of 3 to 6 independent experiments per group.
doi:10.1371/journal.pone.0068167.g002
Figure 3. TNF-induced expression of glomerular adhesion
molecules and chemokines correlates with leukocyte infiltra-
tion in vivo. A: Glomerular expression of adhesion molecules and
proinflammatory chemokines in glomeruli isolated from control mice
(white bars) and from mice 8 hours after intraperitoneal injection of
5 mg TNF (grey bars). mRNA levels were determined by quantitative
real-time PCR, and values were normalized to 18S rRNA as reference
gene. Results are expressed as fold change compared to control
glomeruli. Data shown are means and SE of n = 3 to 6 per group;
p,0.05 versus control. B: Glomerular leukocyte infiltration 8 hours after
intraperitoneal injection of TNF (5 mg) was analysed by compartment-
specific flow cytometry. Leukocyte subpopulations were identified as
follows: leukocytes: CD45+, neutrophils: CD45+ Ly6G+ F4/802, F4/80
positive mononuclear phagocytes: CD45+ F4/80+ Ly6G2, and T cells:
CD45+ CD3e+. Leukocyte numbers are expressed as percentage of all
glomerular cells. p,0.05 versus control.
doi:10.1371/journal.pone.0068167.g003
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were incubated in 6 well plates at 37uC for 24 hours. After serum
starving for further 24 hours glomeruli were stimulated with
indicated concentrations of murine TNF in RPMI 1640 for 12 or
24 hours.
Microarray Studies
For microarray experiments 5,000 glomeruli isolated from
male C57BL/6J wildtype and Tnfr-deficient mice were serum
starved and subsequently stimulated with 50 ng/ml TNF. After
12 hours total RNA was prepared using RNeasy Mini Kit
(Qiagen, Hilden, Germany). Integrity of each RNA sample was
tested by denaturing agarose gel electrophoresis. Three inde-
pendent preparations of 2 mg total RNA per genotype was used
for biotin-labeled complementary RNA probe synthesis and
hybridization of Affymetrix Mouse Genome 430 2.0 arrays
according to the Affymetrix Expression Analysis Technical
Manual. Triplicate arrays per genotype were scanned and
analyzed using the Affymetrix GeneChip Operating Software
(GCOS1.0). The complete data set was deposited into the Gene
Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.
gov/geo/; submission no. GSE43928).
For microarray analysis robust multichip average (RMA) [25]
was performed. All twelve Affymetrix Microarray CEL files were
normalized together using RMA Express, version 1.0 beta 2
(http://rmaexpress.bmbolstad.com/). For probe set annotation
the default Mouse 430_2.cdf was used. Following normalized
RMA, significance analysis of microarrays (SAM) was applied
using the Microsoft Excel plugin of SAM, version 1.21 [26] to
analyze differentially expressed transcripts in Tnfr1,22/2,
Tnfr12/2 and Tnfr22/2 glomeruli compared to wildtype. A q-
value ,5% was used to identify probe sets that detected transcipts
with different expression levels in the analyzed groups. If the same
gene was identified by multiple probe sets, fold-changes to
wildtype were calculated from the averaged signal intensities of
the respective probe sets. Genes with an at least 1.5-fold difference
in mRNA abundance were considered as differentially expressed
between groups.
Ranking of Differentially Expressed Genes by Gene
Ontology
The Database for Annotation, Visualization and Integrated
Discovery (DAVID; accessible at http://david.abcc.ncifcrf.gov)
[27,28] was used to group functionally related genes. DAVID gene
functional classification was applied to rank the overall importance
of functional gene groups that reached an enrichment score of
$1.3. To identify over-represented biological categories (gene
ontology classes) DAVID functional annotation chart was applied
using the functional annotation categories of the Gene Ontology
Consortium for cellular components, biological processes, and
molecular function [27,29]. Based on the Expression Analysis
Systematic Explorer (EASE) [30], annotation terms with EASE
scores of p #0.05, fold enrichment $1.5, and at least 4 genes per
group were considered significant for over-representation in the
given gene list [27]. For all analysis, redundant probe sets for a
given gene were removed before analysis to prevent statistical
biasing.
RNA Isolation and qRT-PCR
Total RNA from cells and isolated tissue was prepared using the
RNeasy Mini Kit (Quiagen). Complementary DNA was generated
from 500 ng of total RNA by reverse transcription (RT) using
random priming and MMLV reverse transcriptase (Invitrogen).
TaqMan real-time PCR was performed on an AB Prism 7000
analyser (Applied Biosystems, Weiterstadt, Germany) using heat-
activated TaqDNA polymerase (Amplitaq Gold, Applied Biosys-
tems). For murine nephrin (NM_019459), VCAM-1
(NM_011693), P-selectin (NM_011347), and GAPDH
(NM_008084) the following oligonucleotide primers (300 nmol/
L) and hydrolysis probes (100 nmol/L) were used (all from Applied
Biosystems): murine nephrin, sense primer 59-ACCCTCCAGT-
TAACTTGTCTTTGG-39, antisense primer 59-ATGCAGCGG
AGCCTTTGA-39, fluorescence labelled probe (FAM) 59-
TCCAGCCTCTCTCC-39; murine VCAM-1, sense primer 59-
AACCCAAACAGAGGCAGAGTGTAC-39, antisense primer
59-GACCCAGATGGTGGTTTCCTT-39, fluorescence labelled
probe (FAM) 59-TGTCAACGTTGCCCC-39, murine P-selectin,
sense primer 59-ATGAA CCCTGTTTTAAACGAAAGC-39,
Figure 4. Differentially expressed genes in Tnfr-deficient glomeruli compared to wildtype after TNF stimulation. Expression profiling
by microarrays was performed on isolated glomeruli from wildtype, Tnfr1,22/2, Tnfr12/2 and Tnfr22/2 mice after stimulation with 50 ng/ml TNF
for 12 hours ex vivo. A: Significance analysis using SAM detected differential regulation of 290 unique genes in Tnfr1,22/2 glomeruli with at least 1.5-
fold difference compared to wildtype (black data points). 219 genes were down-regulated (upper left), and 71 genes were up-regulated (lower right).
B: In Tnfr12/2 mice 219 differentially regulated genes were identified, with lower expression of 159 genes and increased expression of 60 genes. C:
In Tnfr2-deficient glomeruli only 5 genes were differentially expressed, all of them with decreased expression compared to wildtype. In all three
genotypes, expression of the majority of genes with fluorescence signals above background level did not significantly differ from wildtype (grey data
points). Data represent the mean log2 value of fluorescence signals from three independent experiments per genotype.
doi:10.1371/journal.pone.0068167.g004
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Figure 5. Gene expression profiles in wildtype and Tnfr1,2-deficient glomeruli after TNF stimulation ex vivo. Expression profiling by
microarrays was performed on isolated glomeruli from wildtype and Tnfr1,22/2 mice 12 after stimulation with 50 ng/ml TNF for 12 hours ex vivo. A
negativ ‘‘fold change’’ (black to green) indicates decreased expression and a postive ‘‘fold change’’ (black to red) indicates increased expression in a
Glomerular TNFR Functions
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antisense primer 59-CTTGGTTGCTGCAGGAC ATG-39, fluo-
rescence labelled probe (FAM) 59-ACACAGCCTCCTGCC-39,
and murine Gapdh, sense primer 59-
CATGGCCTTCCGTGTTCCTA-39, antisense primer 59-
ATGCCTGCTTCACCACCTTCT-39, fluorescence labelled
probe (VIC) 59-CCCAA TGTGTCCGTCGTGGATCTGA-39:
For murine FXYD2 domain-containing ion transport regulator 2
(Fxyd2; NM_007503), TNFR1 (NM_011609), TNFR2
(NM_011610), CCL2/MCP-1 (NM_011333), CCL3/MIP-1a
(NM_011337), CCL5/RANTES (NM_013653), ICAM-1
(NM_010493), E-selectin (NM_011693), and 18S rRNA commer-
cially available pre-developed TaqMan reagents (Applied Biosys-
tems) were used. For some target genes amplification and PCR
product detection was performed using SYBR Green PCR Master
Mix reagents. The SYBR Green forward (f) and reverse (r)
oligonucleotide primer sequences were as follows: murine Rab6B,
59- GGTTGCCTGGTAGGTGTTGT-39 (f), 59-
GCTGCGAAAATTC AAGTTGG-39 (r); and 18S rRNA, 59-
GCAATTATTCCCCATGAACG-39 (f), 59-AGG GCCTCAC-
TAAACCATCC-39 (r). The expression of candidate genes was
normalized to reference genes GAPDH or 18S rRNA. The
mRNA expression was analyzed by standard curve quantification.
All measurements were performed in duplicates. Controls
consisting of bidistilled H2O and RT
2 controls were negative in
all runs.
Immunohistochemistry
Protein expression of renal TNFR1 and TNFR2 was detected
on 4 mm cryostat sections of OCT-embedded tissue stained with
polyclonal goat anti-mouse TNFR1 and polyclonal goat anti-
mouse TNFR2 antibodies (both from R&D Systems, Wiesbaden,
Germany). Specificity of the antisera was shown by negative
staining of tissue sections from Tnfr1- and Tnfr2-deficient mice,
respectively.
Detection of TNF Receptor Surface Expression by Flow
Cytometry
To detect TNFR1 surface expression glomerular endothelial or
mesangial cells were incubated in fluorescence-activated cell
sorting (FACS) buffer (PBS, 0.2% bovine serum albumin, 0.1%
NaN2) with a monoclonal hamster anti-mouse TNFR1 antibody
(clone 55R-286; BD Biosciences), followed by a biotin-labeled
mouse anti-hamster IgG cocktail (BD Biosciences). Cells were then
stained with phycoerythrin (PE)-conjugated streptavidin (BD
Biosciences). Hamster IgG1 was used as the appropriate isotype
control. TNFR2 expression was analyzed with a PE-conjugated
monoclonal hamster anti-mouse TNFR2 antibody (clone TR75-
89; BD Bioscience). PE-conjugated hamster IgG1 was used as
isotype control.
Chemokine ELISA
Chemokine levels in glomerular culture supernatants were
determined using commercially available ELISA kits for CCL2/
MCP-1, CCL5/RANTES and CXCL10/IP-10 (R&D Systems)
following the manufacturer’s protocols.
Quantification of Glomerular Leukocyte Subsets by Four-
color Flow Cytometry
Single-cell suspensions from glomerular tissue preparations of
individual kidneys were prepared as previously described [31].
Cells were incubated in FACS buffer on ice with combinations
of fluorochrome-labeled antibodies to murine leukocyte surface
markers including PE-conjugated anti-CD45 (clone 30-F11),
FITC-conjugated Ly-6G (clone 1A8), FITC-conjugated CD3e
(clone 145-2C11), allophycocyanin (APC)-conjugated CD4
(clone RM4-5), PE-Cy5-conjugated CD8a (clone 53-6.7) (all
from BD Biosciences), and APC-conjugated F4/80 (clone
CL:A3-1; from AbD serotec, Oxford, UK). Stained cells were
analysed with a FACS CaliburTM flow cytometer and
CellquestTM software (BD Biosciences). The number of
positively stained cells was expressed as percentage of total
glomerular cells.
Statistical Analysis
Numerical results of each experimental group were expressed as
mean6SD or SE as indicated, and were compared using two-
sided non-parametric Mann-Whitney U test. When more than 2
experimental groups were compared, Kruskal-Wallis test was
carried out, followed by pairwise Mann-Whitney U tests.
Significance was assigned to P,0.05.
Results
Expression of TNFR1 and TNFR2 in Mouse Kidney and
Intrinsic Glomerular Cells
Glomeruli were isolated from 6 to 8 week old wildtype mice
after perfusion with paramagnetic Dynabeads (Figure S1A). The
first supernatant obtained during the washing procedure consisted
of a tubulointerstitial tissue fraction that was free of glomeruli
(Figure S1B). To assure the glomerular and tubulointerstitial origin
of the two tissue fractions mRNA expression of glomerular and
tubular marker genes was determined examining nephrin and
FXYD2, the c-subunit of the tubular Na,K-ATPase, respectively
(Figure S1C, S1D).
Compartment-specific quantitative PCR revealed a constitutive
expression of TNFR1 and TNFR2 in normal mouse glomeruli,
with substantially lower transcript levels in tubulointerstitial tissue
(Figure 1A). Consistently, immunohistochemistry demonstrated a
prominent protein expression of TNFR1 and TNFR2 in
glomeruli, but only weak expression in the tubulointerstitium of
normal mice (Figure 1B).
In vitro, glomerular endothelial (Figure 2A, 2B) and
mesangial cells (Figure 2C, 2D) constitutively expressed mRNA
of both TNFRs, with a substantially lower abundance of
TNFR2 mRNA. After stimulation of both cell types with TNF
and IFN-c, TNFR1 mRNA was only upregulated after
challenge with IFN-c or TNF in combination with IFN-c
(Figure 2A, 2C). In contrast, TNFR2 expression was readibly
inducable after incubation with TNF, IFN-c or combined
stimulation (Figure 2B, 2D). As TNF receptors are shed from
the cell surface following ligand binding and activation we next
analyzed surface expression of TNFR1 and TNFR2. In
glomerular endothelial cells cytokine stimulation decreased
glomerular sample compared with the average of all analyzed samples. The 290 differentially regulated genes identified in Tnfr1,22/2 glomeruli are
listed according to fold-change values versus wildtype, starting with the most down-regulated gene (CCL2; -50.0-fold). Note that almost all genes
found significantly regulated in Tnfr1,22/2 glomeruli had a similar trend of expression change in Tnfr12/2 glomeruli, although not reaching
statistical significance in Tnfr12/2 glomeruli for several genes. Table S2 lists all differentially expressed genes with respective probe set IDs, gene
bank accession numbers, gene names and fold-changes according to fold-change values compared to wildtype.
doi:10.1371/journal.pone.0068167.g005
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Figure 6. Gene expression profiles in wildtype, Tnfr1- and Tnfr2-deficient glomeruli after TNF stimulation ex vivo. Expression profiling
by microarrays was performed on isolated glomeruli from wildtype, Tnfr12/2 and Tnfr22/2 mice 12 after stimulation with 50 ng/ml TNF for 12
hours ex vivo. A negativ ‘‘fold change’’ (black to green) indicates decreased expression and a postive ‘‘fold change’’ (black to red) indicates increased
Glomerular TNFR Functions
PLOS ONE | www.plosone.org 8 July 2013 | Volume 8 | Issue 7 | e68167
surface expression of both TNFRs (Figure 2E, 2F). In contrast,
TNFR1 and TNFR2 were not shed from the surface of
mesangial cells upon stimulation, and surface expression of
TNFR2 increased after combined stimulation with TNF and
IFN-c (Figure 2G, 2H), suggesting a robust mesangial TNFR
signaling capacity in inflammatory conditions.
Together, these data demonstrate a constitutive glomerular
expression of both TNFRs in normal mouse kidneys, which can be
induced by proinflammatory stimuli, with TNFR2 being more
readily upregulated than TNFR1.
TNF-induced Expression of Glomerular Adhesion
Molecules and Chemokines Correlates with Glomerular
Leukocyte Infiltration in vivo
8 hours after intraperitoneal injection of 5 mg TNF,
glomerular mRNA expression of adhesion molecules and
chemokines substantially increased, with the highest induction
(42.5-fold) seen for the proinflammatory chemokine CCL2/
MCP-1 (Figure 3A). This was associated with glomerular influx
of CD45+ leukocytes, mainly Ly6C+ neutrophils and F4/80+
mononuclear phagocytes, as revealed by compartment-specific
flow cytometry (Figure 3B). These data demonstrate that TNF-
induced expression of glomerular adhesion molecules and
chemokines results in a rapid glomerular influx of leukocytes,
which may substantially contribute to the glomerular production
of inflammatory mediators. Thus, analysis of TNF-exposed
glomeruli in vivo would not allow the characterization of local
TNFR-mediated inflammatory responses in intrinsic glomerular
cells as opposed to infiltrating leukocytes.
Analysis of TNFR1- and TNFR2-specific Inflammatory
Responses in TNF-stimulated Glomeruli ex vivo by
Microarray Expression Profiling
To examine TNFR-specific inflammatory responses in intrinsic
glomerular cells but not infiltrating leukocytes we stimulated intact
glomeruli isolated from wildtype and Tnfr-deficient mice with
soluble TNF ex vivo. Global gene expression levels were
determined on Affymetrix Mouse Genome 430 2.0 gene chips.
Representative genes differentially expressed in TNF-stimulated
Tnfr1,22/2, Tnfr12/2 and Tnfr22/2 glomeruli compared to
wildtype are listed in Table S1. A comprehensive summary of all
differentially expressed gene sets and genes in Tnfr1,22/2,
Tnfr12/2, and Tnfr22/2 glomeruli compared to wildtype is
shown in Table S2, S3, S4).
In Tnfr1,22/2 glomeruli, i.e. glomeruli without TNF-
signaling capacity, we detected 290 differentially expressed
genes compared to wildtype glomeruli following TNF stimula-
ton, with 219 genes being down-regulated, and 71 genes with
up-reglulated expression (Figure 4A, 5, Table S2). Among these,
168 genes were regulated similarly (i.e. up- or down-regulated)
as in Tnfr12/2 glomeruli (Figure 4B, 6A, Table S3), without
altered expression in Tnfr22/2 glomeruli. Expression of 5
genes was decreased in Tnfr1,22/2 as well as Tnfr22/2
glomeruli (Figure 4C, 6B, Table S4), but not in Tnfr12/2. The
remaining 117 genes were differentially expressed in Tnfr1,22/
2 glomeruli only. However, as shown in Figure 5 all of these
genes had a trend towards similar regulation in Tnfr12/2
glomeruli, with mean fold changes of expression levels mostly
.1.5, although not reaching statistical significance. In contrast,
these genes were not differentially expressed in Tnfr22/2
glomeruli compared to wildtype (Figure 5). Functional groups of
genes expressed in a TNFR1,2-dependent way included cell
expression in a glomerular sample compared with the average of all analyzed samples. A: Compared to wildtype 219 significantly regulated genes
were found in Tnfr12/2 glomeruli. The number of genes identified in Tnfr12/2 glomeruli was lower than in Tnfr1,22/2 glomeruli, but all genes
differentially expressed in Tnfr12/2 glomeruli were regulated similarly in Tnfr1,22/2 glomeruli, although for some genes pair-wise comparison
between Tnfr1,22/2 to wildtype did not reach significance or was below the pre-defined 1.5-fold cut-off (see also Table S3). B: 5 differentially
expressed genes in Tnfr22/2 glomeruli are listed according to fold-change values compared to wildtype. These genes are not differentially
expressed in Tnfr12/2 glomeruli, but 4 of the 5 genes are similarly regulated in Tnfr1,22/2 mice. Tables S3 (Tnfr12/2) and S4 (Tnfr22/2) list all
differentially expressed genes with respective probe set IDs, gene bank accession numbers, gene names and fold-changes according to fold-change
values compared to wildtype.
doi:10.1371/journal.pone.0068167.g006
Table 1. Overrepresented gene ontology terms within differentially expressed genes in TNF-stimulated Tnfr1,22/2 gomeruli 1.
GO term ID GO term name Fold enrichment P-value Gene count
% of regulated
genes
GO:0008009 chemokine activity 19.7 1.29E-10 11.0 3.57
GO:0042379 chemokine receptor binding 19.2 1.70E-10 11.0 3.57
GO:0001664 G-protein-coupled receptor binding 12.0 2.26E-08 11.0 3.57
GO:0002474 antigen processing and presentation of peptide
antigen via MHC class I
11.0 5.36E-03 4.0 1.30
GO:0000270 peptidoglycan metabolic process 9.5 8.31E-03 4.0 1.30
GO:0006958 complement activation, classical pathway 9.1 9.17E-03 4.0 1.30
GO:0042108 positive regulation of cytokine biosynthetic process 8.8 5.48E-04 6.0 1.95
GO:0008217 regulation of blood pressure 8.6 6.08E-04 6.0 1.95
GO:0050727 regulation of inflammatory response 8.6 1.10E-02 4.0 1.30
GO:0031347 regulation of defense response 8.6 1.10E-02 4.0 1.30
1The 10 most overrepresented gene ontology (GO) terms are listed according to their enrichment scores. Terms with an EASE score of p #0.05, fold enrichment $1.5,
and at least 4 genes per group were considered significant for overrepresentation.
doi:10.1371/journal.pone.0068167.t001
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adhesion proteins, proinflammatory chemokines, cytokines and
cytokine receptors, innate immune effectors, antigen presenta-
tion proteins, components of the NF-kB signaling cascade,
matrix metalloproteinases (MMPs), transport proteins, and
signalling molecules (see Table S1), indicating a robust
proinflammatory stimulation of wildtype glomeruli by TNF.
Comparing TNF-stimulated wildtype and Tnfr12/2 glomeruli,
we identified 219 unique genes being differentially expressed
between the two genotypes (Figure 4B, 6A, Table S3). Of these,
159 genes were down-regulated in Tnfr12/2 glomeruli, and 60
were up-regulated. None of these genes was differentially
expressed in Tnfr22/2 glomeruli following TNF-stimulation.
Representative genes differentially expressed in Tnfr12/2
glomeruli are shown in Table S1. The proinflammatory
chemokine CCL2/MCP-1 was the most prominently down-
regulated gene (-42.9-fold) in Tnfr12/2 glomeruli. Of note, the
magnitude of this differential expression was similar to our in vivo
result showing a 42.5-fold induction of glomerular CCL2/MCP-1
mRNA after intraperitoneal TNF injection in wildtype mice
(Figure 3A). TNFR1-dependently expressed genes included several
cell adhesion molecules, proinflammatory chemokines of the CXC
and CC subfamilies, and prototypic proinflammatory cytokines
like pro-interleukin (IL)-1b and IL-6, all of which were down-
regulated in Tnfr12/2 glomeruli. These data suggest a prominent
role for TNFR1 in mediating glomerular leukocyte accumulation
in TNF-stimulated glomeruli. Additionally, effectors and receptors
of the innate immune system, including complement components,
the lipopolysaccharide binding protein, toll-like receptor (TLR) 2,
and proteolytic enzymes like MMP 3, 9, and 13 were down-
regulated in Tnfr1-deficient glomeruli. Many TNFR1-induced
proinflammatory responses are mediated through NF-kB signaling
pathways, and expression of various components and regulators of
the NF-kB signaling cascade was reduced in Tnfr12/2 glomeruli.
Besides proinflammatory genes, several mediators of apoptosis
(including Fas and caspase 12) were expressed TNFR1-depen-
dently.
In contrast to Tnfr12/2, only 5 genes were found to be
differentially expressed in Tnfr22/2 glomeruli, all of which
were down-regulated compared to wildtype (Figure 4C,
Figure 6B, see also Table S1, Table S4). These 5 genes were
not differentially expressed in Tnfr12/2 glomeruli, but expres-
sion of 4 of the 5 genes was also reduced in Tnfr1,22/2
glomeruli (Table S1). Among the 4 TNFR2-dependently
expressed genes (excluding TNFR2) we identified a 2.6-fold
reduced expression of the small GTPase Rab6B in Tnfr22/2
glomeruli (Table S1, Table S4).
In composite, the array data suggest a prominent role of
TNFR1, in contrast to TNFR2, in mediating proinflammatory
effects in glomeruli exposed to soluble TNF.
Enriched Gene Groups and Gene Ontology Classes within
TNFR-dependently Expressed Genes
To further characterize functional roles of TNFR-dependently
expressed genes we analysed Tnfr1,22/2 and Tnfr12/2 regu-
lated gene sets using DAVID and the EASE bioinformatic
algorithms. Due to the few genes identified in Tnfr22/2
glomeruli, this analysis was not performed on the Tnfr22/2
specific gene set. The enriched functional gene groups differen-
tially expressed in Tnfr1,22/2 glomeruli illustrate a robust TNF-
mediated proinflammatory response in intrinsic glomerular cells
(Table S5). Chemokines and cytokines constituted the most
enriched group (enrichment score 8.86), with all members being
downregulated in Tnfr1,22/2 glomeruli compared to wildtype.
Applying the functional annotation chart feature of DAVID we
identified 136 significantly enriched (i.e. overrepresented) gene
ontology categories associated with the differentially regulated
genes in Tnfr1,22/2 glomeruli. Many of the 10 most enriched
gene ontology categories in Tnfr1,22/2 glomeruli were immune-
related, including chemokine activity and chemokine receptor
binding (Table 1).
Enriched gene groups in Tnfr12/2 glomeruli were similar to
Tnfr1,22/2 (Table S6). Again, chemokines and cytokines were
the group with the most significant differential expression
(enrichment score 7.61). Compared to Tnfr1,22/2 glomeruli
DAVID analysis identified fewer, but substantially overlapping
enriched biological terms in Tnfr12/2 glomeruli, with 77
overrepresented categories being associated with the differentially
regulated genes. Among the 10 most enriched gene ontology
categories in Tnfr12/2 glomeruli (Table 2) chemokine activity,
chemokine receptor binding, G-protein-coupled receptor binding,
antigen processing and presentation, and regulation of blood
pressure were identical to those found in Tnfr1,22/2 glomeruli.
Additional highly enriched gene onotology categories were again
Table 2. Overrepresented gene ontology terms within differentially expressed genes in TNF-stimulated Tnfr12/2 glomeruli 1.
GO term ID GO term name Fold enrichment P-value Gene count
% of regulated
genes
GO:0008009 chemokine activity 22.8 3.54E-10 10 4.26
GO:0042379 chemokine receptor binding 22.3 4.53E-10 10 4.26
GO:0002474 antigen processing and presentation of peptide
antigen via MHC class I
14.1 2.69E-03 4 1.70
GO:0001664 G-protein-coupled receptor binding 13.9 3.62E-08 10 4.26
GO:0006953 acute-phase response 12.5 3.79E-03 4 1.70
GO:0008217 regulation of blood pressure 9.2 2.05E-03 5 2.13
GO:0043123 positive regulation of I-kB kinase/NF-kB cascade 8.5 1.15E-02 4 1.70
GO:0002526 acute inflammatory response 8.3 4.97E-05 8 3.40
GO:0006935 chemotaxis 8.2 8.50E-07 11 4.68
GO:0042330 taxis 8.2 8.50E-07 11 4.68
1The 10 most overrepresented gene ontology (GO) terms are listed according to their enrichment scores. Terms with an EASE score of p #0.05, fold enrichment $1.5,
and at least 4 genes per group were considered significant for overrepresentation.
doi:10.1371/journal.pone.0068167.t002
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immune-related, such as acute phase response, positive regulation
of the I-kB kinase/NF-kB cascade, acute inflammatory response,
and chemotaxis (Table 2).
Taken together, these results suggest a predominant role of
TNFR1 in mediating many aspects of soluble TNF-induced
inflammation in the glomerulus. In the presence of TNFR1,
TNFR2 may additionally contribute to TNF signaling in
cooperation with TNFR1, as DAVID analysis identified more
enriched gene ontology terms in Tnfr1,22/2 glomeruli compared
to Tnfr12/2 glomeruli.
Quantitative RT-PCR Analysis of Differentially Regulated
Genes in TNF-stimulated Glomeruli Isolated from
Wildtype and Tnfr-deficient Mice
Microarray expression data were validated by qRT-PCR for
chemokines, adhesion molecules and Rab6B. CCL2/MCP-1
expression was induced in a dose-dependent fashion in TNF-
stimulated wildtype glomeruli, and this induction was completely
abrogated in Tnfr12/2 and Tnfr1,22/2 glomeruli at 12 and
24 hours (Figure 7A). In contrast, CCL2 expression was not
significantly altered in Tnfr22/2 glomeruli at 12 hours
compared to wildtype. However, at 24 hours CCL2 mRNA
levels were significantly reduced after exposure of Tnfr22/2
glomeruli to lower TNF concentrations, i.e 10 ng/ml, with a
similar trend for 25 ng/ml. TNF stimulation with 50 ng/ml
resulted in a comparable induction of CCL2 mRNAs in
Tnfr22/2 and wildtype glomeruli (Figure 7A). Similar results
were found for CCL5/RANTES (Figure 7B) and the adhesion
molecules ICAM-1 (Figure 7C) and VCAM-1 (Figure 7D). We
also analyzed the expression pattern of E-selectin (Figure 7E)
and P-selectin (Figure 7F) in TNF-stimulated glomeruli of all
four genotypes. As shown before in vivo (Figure 3A), we
detected an induced expression of both mRNA species in
wildtype glomeruli in a dose dependent fashion at 12 hours, but
Figure 7. Validation of the array expression pattern by
quantitative RT-PCR. Expression of proinflammatory chemokines
and adhesion molecules in glomeruli isolated from control mice (black
bars), Tnfr12/2 (dark grey bars), Tnfr22/2 (bright grey bars), and
Tnfr1,22/2 mice (white bars) was anlayzed after challenge with
indicated concentrations of TNF in vitro for 12 or 24 hours. The mRNA
levels of CCL2/MCP-1 (A), CCL5/RANTES (B), ICAM-1 (C), VCAM-1 (D), E-
selectin (E), and P-selectin (F) were determined by quantitative real-
time PCR, and values were normalized to 18S rRNA as reference gene.
Data shown are means and SE of n = 3 to 4 per group; p,0.05 versus
wildtype.
doi:10.1371/journal.pone.0068167.g007
Figure 8. Glomerular expression of the small GTPase Rab6B.
Rab6B expression was analyzed in glomeruli isolated from control mice
(black bars), Tnfr12/2 (dark grey bars), Tnfr22/2 (bright grey bars),
and Tnfr1,22/2 mice (white bars) after challenge with indicated
concentrations of TNF in vitro for 12 or 24 hours. The mRNA levels of
Rab6B were determined by quantitative real-time PCR, and values were
normalized to 18S rRNA as reference gene. Data shown are means and
SE of n = 3 per group; p,0.05, p,0.01 versus wildtype.
doi:10.1371/journal.pone.0068167.g008
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not 24 hours. No induction occurred in Tnfr12/2 and
Tnfr1,22/2 glomeruli. This differential expression may have
been missed in the less sensitive microarray studies due to
relative low expression levels. In summary, qRT-PCR confirmed
the microarray data demonstrating a TNFR1-dependent
expression of chemokines and adhesion molecules. Importantly,
in the presence of TNFR1, TNFR2 additionally contributed to
a prolonged expression of inflammatory mediators when
glomeruli were exposed to low TNF concentrations.
In contrast to the TNFR1-dependent induction of chemokines
and adhesion molecules in TNF-stimulated glomeruli, expression
of Rab6B was not substantially altered by TNF exposure in all
four genotypes (Figure 8). However, in unstimulated Tnfr22/2
and Tnfr1,22/2, but not Tnfr12/2 glomeruli we detected
constitutively low expression levels of Rab6B. Compared to
wildtype, glomerular expression of Rab6B remained significantly
reduced after TNF stimulation of glomeruli lacking TNFR2
(Figure 8).
Figure 9. Expression of proinflammatory chemokines and adhesion molecules in TNF-stimulated primary mesangial cells (pMCs).
pMCs were isolated from control mice (black bars), Tnfr12/2 (dark grey bars), Tnfr22/2 (bright grey bars), and Tnfr1,22/2 mice (white bars) after
stimulation with indicated concentrations of TNF in vitro for 12 hours. The mRNA levels of CCL2/MCP-1 (A), CCL5/RANTES (B), ICAM-1 (C), VCAM-1
(D), E-selectin (E), and P-selectin (F) were determined by quantitative real-time PCR, and values were normalized to 18S rRNA as reference gene. Data
shown are means and SE of two independently performed experiments.
doi:10.1371/journal.pone.0068167.g009
Glomerular TNFR Functions
PLOS ONE | www.plosone.org 12 July 2013 | Volume 8 | Issue 7 | e68167
TNF-induced Expression of Chemokines and Adhesion
Molecules in Wildtype and Tnfr-deficient Primary
Mesangial Cells
Resident mesangial cells may substantially contribute to TNF-
induced inflammatory responses in glomeruli. We therefore
analyzed TNF-stimulated primary mesangial cells (pMCs) isolated
from wildtype and Tnfr-deficient glomeruli. Responses of pMCs to
TNF challenge were similar to isolated intact glomeruli. Tnfr1- or
Tnfr1,2-deficiency, but not Tnfr2-deficiency prevented TNF-
induced expression of chemokines and adhesion molecules
(Figure 9A-D). We could not detect a significant expression of E-
and P-selectin in unstimulated or TNF-stimulated pMCs
(Figure 9E, 9F), although expression of both selectins was induced
in TNF-treated intact glomeruli in vivo and in vitro (Figure 3A,
Figure 7E, 7F). These data indicate that mesangial cells
significantly contribute to TNF-induced expression of inflamma-
tory mediators in the glomerulus, although some TNF effects like
up-regulation of selectins are apparently not mediated by
mesangial cells but other glomerular cell types.
Reduced Secretion of Chemokines in TNF-stimulated
Glomeruli from Tnfr12/2, Tnfr22/2 and Tnfr1,22/2
Mice
Consistent with the microarray and qRT-PCR data, TNF-
induced secretion of CCL2/MCP-1, CCL5/RANTES, and
CXCL10/IP-10 in wildtype glomeruli was completely abrogated
in Tnfr12/2 and Tnfr1,22/2 glomeruli (Figure 10). Interesting-
ly, TNF-induced chemokine secretion also significantly decreased
in Tnfr22/2 glomeruli compared to wildtype (Figure 10),
although mRNA expression of chemokines was not significantly
different after stimulation with TNF under the same conditions
(Figure 7, Table S1). Apparently, TNF-induced secretion of these
chemokines is additionally dependent on TNFR2-mediated
posttranscriptional modifications.
Functional Roles of TNFR1 and TNFR2 in TNF-mediated
Glomerular Inflammation in vivo
Does the predominantly TNFR1-mediated inflammatory re-
sponse in TNF-stimulated glomeruli in vitro translate into a
functional role of TNFR1 in glomerular inflammation in vivo? To
address this question we analyzed glomerular leukocyte infiltration
in wildtype and Tnfr-deficient mice 8 hours after intraperitoneal
TNF injection by compartment-specific flow cytometry. TNF-
induced infiltrates of CD45+ leukocytes and Ly6G+ granulocytes
were significantly reduced in Tnfr12/2 and Tnfr1,22/2 mice,
but not in Tnfr22/2 mice (Figure 11A, 11B). Glomerular
accumulation of F4/80+ mononuclear phagocytes decreased in
Tnfr12/2, Tnfr1,22/2 as well as Tnfr22/2 mice, indicating a
non-redundant functional role of both TNFRs for glomerular
phagocyte infiltration in TNF-challenged glomeruli (Figure 11C).
Numbers of glomerular CD3+ T cells were not significantly
different in all four genotypes (Figure 11D), consistent with absent
T cell infiltrates (Figure 3B) within the eight hour time frame
investigated. Together, these experiments reveal a predominant
role of TNFR1 in the recruitment of glomerular leukocytes after
exposure to soluble TNF in vivo, consistent with the identified
in vitro effects of TNFR1 in TNF-challenged glomeruli. In
contrast to neutrophils, TNFR2 contributed to the glomerular
infiltration of F4/80+ leukocytes. This demonstrates an additional
non-redundant role of TNFR2 specifically in the glomerular
recruitment of mononuclear phagocytes, possibly due to its
contribution to prolonged expression of inflammatory mediators
when glomeruli are exposed to low TNF concentrations.
Discussion
The functional role of TNF in glomerular inflammation has
been shown by a variety of experimental studies [1,2]. More recent
data suggested distinct roles of the two TNF receptors in mediating
glomerular inflammation, especially in the setting of immune
complex GN [20] or collapsing glomerulopathies [32]. Tnfr1-
deficiency delayed the onset of GN, but absent TNFR2 signaling
Figure 10. Secretion of proinflammatory chemokines by TNF-
stimulated glomeruli ex vivo. Concentrations of CCL2/MCP-1, CCL5/
RANTES, and CXCL10/IP-10 were measured by ELISA in culture
supernatants of wildtype, Tnfr12/2, Tnfr22/2, and Tnfr1,22/2
glomeruli 12 hours after stimulation with 50 ng/ml of TNF. Data shown
are means and SD of n = 3 per group; p,0.05 versus wildtype.
doi:10.1371/journal.pone.0068167.g010
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in intrinsic renal cells protected from nephritis [20]. These studies
demonstrate that resident glomerular cells differently respond to
TNFR1 and TNFR2 activation during local, e.g. immune
complex-mediated injury. To better understand underlying
TNFR-specific inflammatory pathways in parenchymal glomeru-
lar cells that would explain the observed in vivo phenotypes in
Tnfr-deficient mice, we analysed isolated intact glomeruli stimu-
lated with soluble TNF ex vivo. This approach excluded
additional changes of glomerular gene expression by leukocytes,
which, as we show, readily accumulated in glomeruli following
TNF exposure in vivo.
In comparison of wildtype and Tnfr1,2-deficient glomeruli
without TNF signaling capacity, the results of our microarray
experiments demonstrate that TNF induced expression of many
innate immune effectors in intrinsic glomerular cells. All of these
have been shown to be essential for glomerular leukocyte
recruitment and activation, including adhesion molecules, chemo-
kines and cytokines [33,34,35,36], components of the complement
system [37,38], and metalloproteinases [39,40]. Many inflamma-
tory functions of TNF are induced via activation of the NF-kB
signaling cascade. TNF treatment induced expression of several
NF-kB transcription family members in wildtype glomeruli, as
compared to Tnfr1,22/2 glomeruli, creating pathogenic feed-
forward NF-kB loops in TNF-stimulated glomeruli.
When we compared TNF-induced gene expression between
wildtype and Tnfr1-deficient glomeruli, differentially expressed
genes and functional groups were similar to Tnfr1,22/2
glomeruli, indicating a predominant role of TNFR1 signaling in
TNF-mediated glomerular effects. However, overall less genes
were significantly regulated in Tnfr12/2 than Tnfr1,22/2
glomeruli, which suggests a contribution of TNFR2 to the
inflammatory response in glomeruli when TNFR1 is present.
This TNFR1-dependent synergistic effect of TNFR2 was also
suggested by the qRT-PCR studies that examined expression
profiles of selected chemokines and adhesion molecules in
glomeruli challanged with increasing TNF concentrations up to
24 hours. In these experiments, low TNF concentrations did not
induce mRNAs of these molecules in both Tnfr12/2 and
Tnfr22/2 glomeruli as they did in wildtype glomeruli. In
contrast, when glomeruli were stimulated with higher concentra-
tions up to 50 ng/ml, expression of adhesion molecules and
chemokines was induced in Tnfr22/2, but not Tnfr12/2
glomeruli. Thus, in the presence of TNFR1, activation of TNFR2
may enhance proinflammatory TNF signaling when cells are
stimulated with low concentrations of TNF for a prolonged time.
This may result from the formation of receptor heterocomplexes
[41] or a process referred to as ligand passing in which TNFR2-
bound TNF increases the local TNF concentration in the vicinity
of TNFR1 [42].
Figure 11. Contribution of TNFR1 and TNFR2 signaling to TNF-mediated infiltration of glomerular leukocytes. Compartment-specific
flow cytometry was performed on glomerular tissue prepared from wildtype, Tnfr12/2, Tnfr22/2, and Tnfr1,22/2mice 8 hours after intraperitoneal
injection of 5 mg TNF. Leukocyte subpopulations were identified as follows: A: CD45+ leukocytes, B: CD45+ Ly6G+ F4/802 neutrophils, C: CD45+ F4/
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Surprisingly, our microarray analysis identified only 4 genes
that were differentially regulated in Tnfr22/2 glomeruli com-
pared to wildtype. These genes were not differentially expressed in
Tnfr1-deficient glomeruli. The only well-characterized gene within
this group was Rab6B, a small intracellular GTPase. Subsequent
qRT-PCR analysis revealed that Rab6B expression was constitu-
tively suppressed in Tnfr22/2 and Tnfr1,22/2, but not Tnfr12/
2 glomeruli, and was not induced after TNF stimulation. The
reason for the TNFR2-dependent expression of Rab6B is not
known, nor have functions of renal cell-expressed Rab6B been
described. Proteins of the Rab family are important intracellular
regulators of vesicular traffic in the secretory and endocytotic
pathways [43,44]. To this end, deficient Rab6B expression in
Tnfr22/2 glomeruli may compromise the cellular capacity to
secrete TNF-induced inflammatory mediators and contribute to
reduced chemokine secretion, which we observed in TNF-
stimulated Tnfr22/2 glomeruli, despite comparable mRNA
expression levels with wildtype. Importantly, the latter finding
identified a novel posttranscriptional role of glomerular TNFR2
which contributes to local chemokine production.
The lack of exclusively TNFR2-dependently expressed genes in
our expression analysis was unexpected. Our data suggest that
proinflammatory effects in parenchymal glomerular cells stimu-
lated with soluble TNF are almost exclusively mediated via
TNFR1 signaling, with only minor contributions of TNFR2 when
TNFR1 is present. Our microarray data were confirmed by qRT-
PCR analysis of TNF-stimulated glomeruli and mesangial cells,
and importantly correlate in vivo with completely abrogated
glomerular leukocyte infiltration in Tnfr1-, but not Tnfr2-deficient
mice after intraperitoneal challenge with soluble TNF. In contrast,
Bruggeman et al. recently reported a TNFR2-mediated NF-kB-
dependent inflammatory response in immortalized podocytes
stimulated with soluble TNF in vitro, without requirement for
TNFR1 [32]. Although our data on isolated intact glomeruli do
not rule out a contribution of podocyte-expressed TNFR2 to the
proinflammatory TNFR2-dependent glomerular effects revealed
in this study, we could not identify a TNFR1-independent function
of TNFR2 in intact glomeruli ex vivo or TNF-stimulated mice
in vivo. TNFR activation, however, may be different in podocytes
located within intact glomeruli and immortalized podocytes
cultures in vitro. Moreover, as all intrinsic glomerular cells
(glomerular endothelial and mesangial cells as shown in this
study, and podocytes [32]) can express TNFR1 and TNFR2, their
relative contributions to TNF-induced glomerular injury remains
to be elucidated analysing mice with cell type-specific deletion of
these receptors.
Absence of the TNFR1-mediated proinflammatory effects
identified in this study may well explain the delayed onset of
GN in Tnfr1-deficient mice in vivo described previously [20]. As
stimulation of intact glomeruli and mesangial cells with soluble
TNF did not reveal any exclusively TNFR2-mediated inflamma-
tory effects, potential mechanisms leading to protection from GN
in Tnfr2-deficient mice [20] may involve activation of renal cell-
expressed TNFR2 by membrane-bound TNF. This hypothesis is
supported by findings that glomerular as opposed to systemic TNF
mediates renal injury in GN, either expressed by activated
adjacent glomerular cells [15,16] or infiltrating macrophages
[45]. Moreover, in contrast to soluble TNF which efficiently
activates TNFR1 in vitro [46], membrane-bound TNF has been
suggested to preferentially activate TNFR2 [47]. The high affinity
of soluble TNF for TNFR1 apparently results from a marked
stability of ligand receptor complexes, as opposed to transient
interactions of soluble TNF with TNFR2 [46]. On the other hand,
membrane-bound TNF was superior to soluble TNF in mediating
TNFR2-dependent T cell activation, thymocyte proliferation, and
granulocyte/macrophage colony-stimulating factor production
[47]. Moreover, recent evidence indicates that TNFR2 activation
induces degradation of TNF receptor-associated factor 2 (TRAF2),
a key mediator of signal transduction of both TNFR1 and TNFR2
which is required for transcriptional activation of target genes [48].
When TNFR1 and TNFR2 were activated simultaneously,
TNFR2-induced TRAF2 degradation and the subsequent de-
crease in NF-kB activation resulted in an enhancement of
cytotoxicity triggered by TNFR1 [49,50]. Importantly, it was
shown that TNFR2 is also able to trigger a cell death process that
is independent of TNFR1 activation after upregulation of
membrane-bound TNF and TNFR2, potentially involving
necroptosis [50,51]. In the context of GN these data suggest that
glomerular activation of TNFR2 by membrane-bound TNF may
trigger local cell injury which is essential for the induction of
nephritis, as shown in the NTN model in vivo [20].
In summary, our glomerular expression analysis and in vivo
studies identified TNFR1 as the major receptor mediating
proinflammatory effects of soluble TNF in intrinsic glomerular
cells. In the presence of TNFR1, TNFR2 contributes to this
inflammatory response when glomeruli are stimulated with low
TNF concentrations and promotes chemokine secretion. The
potential contribution of membrane-bound TNF to TNFR2-
dependent glomerular inflammation remains to be elucidated.
Supporting Information
Figure S1 Isolation of glomerular and tubulointerstitial
tissue fractions from mouse kidneys. A: Appearance of
mouse glomeruli isolated after paramagnetic bead perfusion. B:
The tubulointerstitial tissue fraction obtained during the first wash
of the glomerular isolation procedure contained tubular fragments,
tubular cells and polymorphic interstitial cells. Original magnifi-
cation6100 (A–B). C: mRNA expression of the glomerular
marker gene nephrin and D: FXYD2, the c-subunit of the
tubular Na,K-ATPase, in glomerular and tubulointerstitial tissue
from wildtype mice as analyzed by quantitative real-time PCR.
Values were normalized to rRNA expression used as reference
gene. p,0.05.
(TIF)
Table S1 Representative genes differentially expressed in TNF-
stimulated Tnfr1,22/2, Tnfr12/2 and Tnfr22/2 glomeruli
compared to wildtype as identified by microarray profiling.
(PDF)
Table S2 Differentially expressed genes in TNF-stimulated
Tnfr1,22/2 glomeruli compared to wildtype as identified by
microarray profiling.
(PDF)
Table S3 Differentially expressed genes in TNF-stimulated
Tnfr12/2 glomeruli compared to wildtype as identified by
microarray profiling.
(PDF)
Table S4 Differentially expressed genes in TNF-stimulated
Tnfr22/2 glomeruli compared to wildtype as identified by
microarray profiling.
(PDF)
Table S5 Enriched functional groups of differentially expressed
genes in TNF-stimulated Tnfr1,22/2 glomeruli compared to
wildtype as identified by DAVID.
(PDF)
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Table S6 Enriched functional groups of differentially expressed
genes in TNF-stimulated Tnfr12/2 glomeruli compared to
wildtype as identified by DAVID.
(PDF)
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